Hatfield, England (ots/PRNewswire) - New EMEA Dubai Office Part of Expansion Plans into Middle East and Parts of Africa PRESS RELEASE NOT INTENDED FOR DUBAI MEDIA Japanese company Eisai is expanding its geographical and patient reach by opening a new regional representative office in Dubai today. The Eisai EMEA (Europe, Middle East and Africa) Dubai branch office, located in Dubai Healthcare City (DHCC), marks the ...
Monheim, Germany (ots/PRNewswire) - Four WebConferences from 7th International CVBD World Forum attract more than 3,000 viewers from around the world to hear case studies from leading international experts Bayer Animal Health today announced that the recent educational WebConfererences following the Seventh Canine Vector-Borne Disease (CVBD) World Forum were watched by ...
Hatfield, England (ots/PRNewswire) - Child-friendly formulation now available for the treatment of Lennox-Gastaut syndrome Eisai Europe Limited today announced the launch of Inovelon(R) (rufinamide) oral suspension in Denmark for adjunctive (add-on) treatment of seizures associated with Lennox-Gastaut syndrome (LGS), in children four years and older. Many patients who receive the orphan drug rufinamide are children, ...
Shire Pharmaceuticals Group Plc
Dublin (ots/PRNewswire) - Shire plc , the global specialty biopharmaceutical company, will announce first quarter 2012 earnings on Thursday April 26, 2012. Results press release will be issued at: 12:00 BST / 07:00 EDT Investor conference call time: 14:00 BST / 09:00 EDT Live conference call for investors: Angus Russell, Chief Executive Officer and Graham Hetherington, ...
Shire Pharmaceuticals Group Plc
Dublin (ots/PRNewswire) - Shire plc , the global specialty biopharmaceutical company, today announced that it has signed an agreement to acquire substantially all the assets of Pervasis Therapeutics. Shire will provide Pervasis with an upfront payment, plus potential post-closing milestone payments that are dependent on Shire's achievement of certain clinical ...
Birmingham, England (ots/PRNewswire) - Not Intended For UK Media New collar from Bayer Animal Health offers dogs and cats an unparalleled protection period of up to eight months from ticks and fleas in a single treatment Bayer Animal Health today launched Seresto (known as Foresto in some European markets*), the latest in a long line of innovative anti-parasite products from one of the world's leading animal health ...
London (ots/PRNewswire) - Nutricia Advanced Medical Nutrition, the specialised healthcare unit of Danone, will serve as a partner in the implementation stage of the Active and Healthy Ageing (AHA) project, the EU-led initiative intended to help older Europeans enjoy a more active and healthy life. The announcement ...
Tokyo (ots/PRNewswire) - ? Hoya Corporation's Vision Care Division, a key player in the global market for ophthalmic lenses, today announced the acquisition of Optotal Hoya S.A., its exclusive partner in Brazil. Optotal operates the largest prescription lens (Rx) laboratory and one of the largest wholesale distribution networks in the ophthalmic lens market in Brazil. HOYA's cooperation with Optotal started in 1992 with a ...
Shire Pharmaceuticals Group Plc
Philadelphia, Pennsylvania (ots/PRNewswire) - Shire plc , the global specialty biopharmaceutical company, today announced top-line results of the PREVENT2 trial, a phase 3 investigational study of once-daily SPD476, MMX(R) mesalamine in patients with a history of diverticulitis.[1] The study, conducted in 10 countries worldwide including the United States, did not meet the primary endpoint in reducing the rate of ...
Monheim, Germany (ots/PRNewswire) - As part of its ongoing commitment to the scientific community, Bayer Animal Health today marked their seventh year of support for the CVBD World Forum (CVBD7) in Berlin, Germany; and this year's meeting has again proven to be a landmark in the understanding of CVBDs. CVBDs present ...
http://resources.euroadhoc.com/us/JrNcWOXN issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard: SIX Swiss ...
Astellas Pharma Europe Limited
Staines, England (ots/PRNewswire) - ASTELLAS PHARMA EUROPE Ltd., the European subsidiary of Tokyo - based Astellas Pharma Inc. today announced the submission of a Market Authorisation Application for EC905 in the Netherlands. This application for approval is the first step of the European-wide mutual recognition ...
http://resources.euroadhoc.com/us/CR4ucQv9 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
The International Osteoporosis Foundation (IOF)
Bordeaux, France (ots) - Today, at the European Congress on Osteoporosis & Osteoarthritis, healthcare experts and national patient society advocates from around the world attended a special session devoted to the problem of secondary fractures and their prevention. At the heart of the problem is the fact that a ...
Geneva (ots/PRNewswire) - Results Reconfirm Test's Cost-Effectiveness, Emphasise Important Role in Guiding Treatment Decisions Genomic Health, Inc. today announced results of three new Oncotype DX(R) studies including data demonstrating the test's cost-effectiveness within the German and Hungarian healthcare ...
Minneapolis And Geneva (ots/PRNewswire) - Milestone comes 25 years after the first DBS implant for Tremor carried out in Grenoble, France Medtronic, Inc. today announced that a patient from Kempenhaeghe-Heeze (The Netherlands) is the first patient to be enrolled into the MORE (MedtrOnic Registry for Epilepsy) ...
Shire Pharmaceuticals Group Plc
Dublin (ots/PRNewswire) - ? Shire plc , the global specialty biopharmaceutical company, announces that it has signed an agreement to acquire FerroKin BioSciences, Inc., for an upfront payment of $100 million, payable in cash at closing, plus potential post-closing milestone payments of up to $225 million, depending upon the achievement of certain clinical development, ...
Bangalore, India, London, And New York (ots/PRNewswire) - An Integrated Platform and Services Solution to Streamline Global Digital Engagement Infosys Ltd , today, announced its partnership with GlaxoSmithKline (GSK) to optimize digital channels across its global consumer healthcare and pharmaceuticals business ...
http://resources.euroadhoc.com/us/Rd8E7zsy issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Bern, Switzerland (ots) - - - Quality of Life (QoL) is strongly diminished in RVVC patients - Current available treatment fails in two thirds of patients - High medical need demands novel effective treatment options Pevion Biotech AG today announced results from a large, international survey on the Quality of Life ...
Shire Pharmaceuticals Group Plc
Nyon, Switzerland (ots/PRNewswire) - Shire plc , the global specialty biopharmaceutical company, today announced it has received approval through the European Decentralised Procedure for an oral powder formulation of FOSRENOL (lanthanum carbonate). FOSRENOL is a non-calcium, non-resin phosphate binder indicated as a phosphate binding agent for use in the control of ...
Hitachi Medical Systems Europe Holding AG
Zug, Switzerland (ots) - - - First ECR presentation of the combined Hitachi and Aloka ultrasound portfolio with its many highlights - New upgrades for ProSound F75 - New ergonomic lightweight ultrasound system F37 - Image fusion with Hitachi Real-time Virtual Sonography - A new era in MR imaging: the Echelon Oval ...
E.S.PKU (European Society for Phenylketonuria and Allied Disorders Treated as Phenylketonuria)
Brussels (ots/PRNewswire) - - World Rare Disease Day 2012 Today, on World Rare Disease Day, the European Society for Phenylketonuria and Allied Disorders (E.S.PKU) urged policy makers to bridge significant gaps in Phenylketonuria (PKU[1]) care across Europe during a lunch debate at the European Parliament. The ...
http://resources.euroadhoc.com/us/FKLabGTF issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Staines, England (ots/PRNewswire) - The Astellas European Foundation is delighted to announce the winner of the 2012 Urology Grant: Dr Gommert Van Koeveringe from Maastricht University Medical Center, the Netherlands The team including Dr Daisy Vrijens from Maastricht University and Professor Matthias Oelke from the University of Hannover, Germany received the grant of ...
Astellas Pharma Europe Limited
Paris (ots/PRNewswire) - ASTELLAS PHARMA EUROPE Ltd., European subsidiary of Tokyo-based Astellas Pharma Inc. today announced results from three separate clinical trials that further support the efficacy and tolerability of mirabegron. Mirabegron, a beta3 adrenoceptor agonist, is the first in a new class of ...
http://resources.euroadhoc.com/us/9HSfZYNF issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
http://resources.euroadhoc.com/us/FXCyZ1yC http://resources.euroadhoc.com/us/zkFOkW65 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: ...
Stockholm (ots/PRNewswire) - A double-blind, placebo-controlled study of 494 children showed that supplementation of Lactobacillus reuteri Protectis significantly reduced episodes of diarrhoea. Lactobacillus reuteri Protectis was particularly effective in children with lower nutritional status. Another probiotic strain, which was also tested, was without effect. Study design The six month long double-blind, ...
Ecole Polytechnique de Montreal
Montreal (ots/PRNewswire) - Researchers at Polytechnique Montréal have succeeded in changing the genetic material of cancer cells using a brand-new transfection method. This major breakthrough in nanosurgery opens the door to new medical applications, among others for the treatment of cancers. A light scalpel to treat cancerous cells The unique method developed by ...